The Koch Institute for Integrative Cancer Research at MIT

Mosaic of colored tiles and images of research and people

Celebrating 50 years of collaboration, innovation, and curiosity in cancer research at MIT

Join us 

Our Research Areas

From fundamental discoveries to engineering advances, we strategically pursue five areas of research that, across tumor types, are critical for rapid progress toward defeating cancer. 

Detection & monitoring  
Metastasis  
Immunology & immunotherapy  
Nano-based drugs  
Precision medicine  

News

Fast track to healing could spell tumor trouble

MIT News

August 21, 2024

A new study from the Yilmaz Lab demonstrates the benefits and downside of fasting.

While low-calorie diets and intermittent fasting are known to boost intestinal regeneration and aid recovery from injuries or inflammation, this study, published in Nature, reveals something new: it also leads to a higher risk of cancer in mice. Further studies are needed before forming any conclusion as to whether fasting has a similar effect in humans.

This research was funded in part by the MIT Stem Cell Initiative, the Koch Institute Frontier Research Program via the Kathy and Curt Marble Cancer Research Fund, and the Bridge Project.
 

Meet the 2024 Amon Award Winners

MIT Koch Institute

The Koch Institute at MIT is pleased to announce the winners of the 2024 Angelika Amon Young Scientist Award, Anna Uzonyi and Lukas Teoman Henneberg. 

Cancer moonshot boosts CisionVision

PR Newswire

CisionVision, co-founded by KI’s Angela Belcher and former trainee and Convergence Scholar Jeremy Li, has secured up to $22 million from the Advanced Research Projects Agency for Health (ARPA-H) Precision Surgical Interventions (PSI) program.

More News 

At the Koch Institute for Integrative Cancer Research, scientists and engineers work together to solve some of the most difficult problems in cancer. We ask big questions in strategic areas, where the answers have big impacts on how we understand and treat cancer.